Concepedia

Rheumatoid Arthritis–Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment

Sicong Huang, Vanessa L. Kronzer, Paul F. Dellaripa, Kevin D. Deane, Marcy B. Bolster, Vivek Nagaraja, Dinesh Khanna, Tracy J. Doyle, Jeffrey A. Sparks

Current Treatment Options in Rheumatology · 2020 · 73 citations · 81 references

DOIFull text

Open access

Concepts

References

81

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

, , +13

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis, Ulrich Costabel, David M. Hansell et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 4.3K citations · Full text

, , +14

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Kevin R. Flaherty, Athol U. Wells, Vincent Cottin et al. · New England Journal of Medicine · 2019 · 2.3K citations · Full text

, , +11

Prednisone, Azathioprine, and <i>N</i> -Acetylcysteine for Pulmonary Fibrosis

New England Journal of Medicine · 2012 · 1.6K citations · Full text

, , +13

A Common <i>MUC5B</i> Promoter Polymorphism and Pulmonary Fibrosis

Max A. Seibold, Anastasia L. Wise, Marcy C. Speer et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

, , +13